Radnet Inc (RDNT) 8.66 $RDNT
5 Stocks Ready for Breakouts: Qiwi, RadNet and More
at The Street - Fri Feb 06, 9:03AM CST
These stocks are poised to break out and trade higher from current levels.
QIWI: 25.16 (+1.45), RDNT: 8.66 (-0.11), TPLM: 5.68 (+0.06), DWCH: 6.26 (-0.18), DSCO: 1.43 (+0.05)
Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:37PM CST
Quest Diagnostics' (DGX) fourth-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.08 exceeded the Zacks Consensus Estimate by 3 cents.
AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
RadNet Up 23.2% Since SmarTrend Uptrend Call (RDNT)
Comtex SmarTrend(R) - Tue Jan 13, 11:18AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 23.15% as of today's recent price of $8.51.
RDNT: 8.66 (-0.11)
Uptrend Call Working As RadNet Stock Rises 21.3% (RDNT)
Comtex SmarTrend(R) - Tue Jan 06, 10:29AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 21.28% as of today's recent price of $8.38.
RDNT: 8.66 (-0.11)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 4:50PM CST
INSY: 51.50 (-0.66), DNOW: 25.64 (+0.70), MTRX: 19.92 (+0.77), RDNT: 8.66 (-0.11), ONVO: 6.34 (+0.07), PES: 5.74 (+0.54), RUSS: 11.59 (-0.81), CEMP: 27.68 (+1.25), LPI: 13.25 (+0.81), HTA: 27.93 (-0.24)
40.2% Return Seen to Date on SmarTrend RadNet Call (RDNT)
Comtex SmarTrend(R) - Mon Dec 29, 9:34AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 40.23% as of today's recent price of $9.69.
RDNT: 8.66 (-0.11)
RadNet Shares Up 24.5% Since SmarTrend's Buy Recommendation (RDNT)
Comtex SmarTrend(R) - Mon Dec 22, 9:23AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 24.46% as of today's recent price of $8.60.
RDNT: 8.66 (-0.11)
Cramer's Mad Money - Look At Red Hat Go (12/19/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Dec 21, 4:26AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday December 19. CEO Interview, James Whitehurst, Red Hat (NYSE: RHT ) "Look at Red Hat ( RHT ) run." The stock dominates Open Source software for...
BLUE: 90.70 (+0.93), GPRO: 45.27 (-0.02), AVP: 9.08 (+0.39), SYNA: 78.91 (+0.87), NKE: 92.04 (+0.04), SKX: 66.09 (-0.06), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSIQ: 28.84 (-0.30), PAYX: 48.76 (+0.36), RDNT: 8.66 (-0.11), KITE: 62.59 (+0.82), RHT: 68.47 (+0.57), HAWK: 36.59 (-0.49), JUNO: 40.52 (+0.18), PAY: 35.98 (+1.30), WAG: 76.05 (-0.49)
United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.54 (+0.03), BRLI: 34.63 (+0.06), RDNT: 8.66 (-0.11), NEO: 4.10 (unch), DGX: 71.68 (+0.03), LH: 116.90 (+0.06), GHDX: 31.12 (+0.28)
Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders
at The Street - Thu Dec 11, 12:15PM CST
Stocks with insider trader activity include CDW, CGIX and RDNT
RDNT: 8.66 (-0.11), CGIX: 7.07 (unch), CDW: 37.03 (+0.63)
RadNet (RDNT): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:48AM CST
One stock that might be an intriguing choice for investors right now is RadNet as this security in the Pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
RDNT: 8.66 (-0.11)
Shares of RDNT Up 22.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 05, 11:30AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 4 months, RadNet has returned 22.14% as of today's recent price of $8.44.
RDNT: 8.66 (-0.11)
Elite Imaging Selects Comprehensive eRAD Platform
GlobeNewswire - Mon Dec 01, 10:10AM CST
eRAD, a subsidiary of RadNet, Inc. (Nasdaq:RDNT), a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Elite Imaging will leverage a comprehensive suite of eRAD solutions to achieve its ambitious growth strategy.
RDNT: 8.66 (-0.11)
Reno Diagnostic Centers Implement eRAD RIS and RADAR for Efficiency Gains
GlobeNewswire - Fri Nov 28, 10:43AM CST
eRAD, a subsidiary of RadNet, Inc. (Nasdaq:RDNT), a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Reno Diagnostic Centers (RDC) has implemented eRAD RIS to manage front office and radiologist workflow and RADAR for clinical communication, including patient appointment reminders.
RDNT: 8.66 (-0.11)
Great Lakes Orthopedics and Sports Medicine Scales With eRAD PACS
GlobeNewswire - Tue Nov 25, 1:43PM CST
Great Lakes Orthopedics and Sports Medicine, a multi-service specialty group with three locations in northern Indiana, has deployed eRAD PACS to support its high standard of patient care as it expands to multiple locations.
RDNT: 8.66 (-0.11)
Midwest Advanced Radiology Center Implements Full eRAD Platform
GlobeNewswire - Fri Nov 21, 9:47AM CST
Midwest Advanced Radiology Center (MRAD), a multi-modality outpatient imaging facility with two locations in the northern Chicago suburbs, has deployed a comprehensive suite of eRAD solutions to automate its business and clinical workflow.
RDNT: 8.66 (-0.11)
Uptrend Call Working As RadNet Stock Rises 17.9% (RDNT)
Comtex SmarTrend(R) - Fri Nov 21, 9:44AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 4 months, RadNet has returned 17.95% as of today's recent price of $8.15.
RDNT: 8.66 (-0.11)
5 Stocks Ready for Breakouts: Qiwi, RadNet and More
at The Street - Fri Feb 06, 9:03AM CST
These stocks are poised to break out and trade higher from current levels.
QIWI: 25.16 (+1.45), RDNT: 8.66 (-0.11), TPLM: 5.68 (+0.06), DWCH: 6.26 (-0.18), DSCO: 1.43 (+0.05)
Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:37PM CST
Quest Diagnostics' (DGX) fourth-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.08 exceeded the Zacks Consensus Estimate by 3 cents.
AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
RadNet Up 23.2% Since SmarTrend Uptrend Call (RDNT)
Comtex SmarTrend(R) - Tue Jan 13, 11:18AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 23.15% as of today's recent price of $8.51.
RDNT: 8.66 (-0.11)
Uptrend Call Working As RadNet Stock Rises 21.3% (RDNT)
Comtex SmarTrend(R) - Tue Jan 06, 10:29AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 21.28% as of today's recent price of $8.38.
RDNT: 8.66 (-0.11)
After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 4:50PM CST
INSY: 51.50 (-0.66), DNOW: 25.64 (+0.70), MTRX: 19.92 (+0.77), RDNT: 8.66 (-0.11), ONVO: 6.34 (+0.07), PES: 5.74 (+0.54), RUSS: 11.59 (-0.81), CEMP: 27.68 (+1.25), LPI: 13.25 (+0.81), HTA: 27.93 (-0.24)
40.2% Return Seen to Date on SmarTrend RadNet Call (RDNT)
Comtex SmarTrend(R) - Mon Dec 29, 9:34AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 40.23% as of today's recent price of $9.69.
RDNT: 8.66 (-0.11)
RadNet Shares Up 24.5% Since SmarTrend's Buy Recommendation (RDNT)
Comtex SmarTrend(R) - Mon Dec 22, 9:23AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 5 months, RadNet has returned 24.46% as of today's recent price of $8.60.
RDNT: 8.66 (-0.11)
Cramer's Mad Money - Look At Red Hat Go (12/19/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Dec 21, 4:26AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Friday December 19. CEO Interview, James Whitehurst, Red Hat (NYSE: RHT ) "Look at Red Hat ( RHT ) run." The stock dominates Open Source software for...
BLUE: 90.70 (+0.93), GPRO: 45.27 (-0.02), AVP: 9.08 (+0.39), SYNA: 78.91 (+0.87), NKE: 92.04 (+0.04), SKX: 66.09 (-0.06), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSIQ: 28.84 (-0.30), PAYX: 48.76 (+0.36), RDNT: 8.66 (-0.11), KITE: 62.59 (+0.82), RHT: 68.47 (+0.57), HAWK: 36.59 (-0.49), JUNO: 40.52 (+0.18), PAY: 35.98 (+1.30), WAG: 76.05 (-0.49)
United States Medical and Diagnostic Laboratories Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts
M2 - Mon Dec 15, 8:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/k6lcqc/medical_and) has announced the addition of Plunkett Research Ltd's new report "Medical and Diagnostic Laboratories Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Medical and Diagnostic Laboratories Industry (U.S.) to reach $80.8 billion by 2021. - Medical and Diagnostic Laboratories Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2013 - Income Statements. Balance Sheets and Cash Flow Statements Companies Mentioned - Alliance Healthcare Services Inc - AmeriPath Inc - Bio-Reference Laboratories Inc - Genomic Health Inc - Hooper Holmes Inc - Laboratory Corp of America Holdings - MEDTOX Scientific Inc - NeoGenomics Inc - Quest Diagnostics Inc - RadNet Inc For more information visit http://www.researchandmarkets.com/research/k6...edical_and Source: Plunkett Research Ltd
HH: 0.54 (+0.03), BRLI: 34.63 (+0.06), RDNT: 8.66 (-0.11), NEO: 4.10 (unch), DGX: 71.68 (+0.03), LH: 116.90 (+0.06), GHDX: 31.12 (+0.28)
Insider Trading Alert - CDW, CGIX And RDNT Traded By Insiders
at The Street - Thu Dec 11, 12:15PM CST
Stocks with insider trader activity include CDW, CGIX and RDNT
RDNT: 8.66 (-0.11), CGIX: 7.07 (unch), CDW: 37.03 (+0.63)
RadNet (RDNT): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 7:48AM CST
One stock that might be an intriguing choice for investors right now is RadNet as this security in the Pharmaceutical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
RDNT: 8.66 (-0.11)
Shares of RDNT Up 22.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 05, 11:30AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 4 months, RadNet has returned 22.14% as of today's recent price of $8.44.
RDNT: 8.66 (-0.11)
Elite Imaging Selects Comprehensive eRAD Platform
GlobeNewswire - Mon Dec 01, 10:10AM CST
eRAD, a subsidiary of RadNet, Inc. (Nasdaq:RDNT), a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Elite Imaging will leverage a comprehensive suite of eRAD solutions to achieve its ambitious growth strategy.
RDNT: 8.66 (-0.11)
Reno Diagnostic Centers Implement eRAD RIS and RADAR for Efficiency Gains
GlobeNewswire - Fri Nov 28, 10:43AM CST
eRAD, a subsidiary of RadNet, Inc. (Nasdaq:RDNT), a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Reno Diagnostic Centers (RDC) has implemented eRAD RIS to manage front office and radiologist workflow and RADAR for clinical communication, including patient appointment reminders.
RDNT: 8.66 (-0.11)
Great Lakes Orthopedics and Sports Medicine Scales With eRAD PACS
GlobeNewswire - Tue Nov 25, 1:43PM CST
Great Lakes Orthopedics and Sports Medicine, a multi-service specialty group with three locations in northern Indiana, has deployed eRAD PACS to support its high standard of patient care as it expands to multiple locations.
RDNT: 8.66 (-0.11)
Midwest Advanced Radiology Center Implements Full eRAD Platform
GlobeNewswire - Fri Nov 21, 9:47AM CST
Midwest Advanced Radiology Center (MRAD), a multi-modality outpatient imaging facility with two locations in the northern Chicago suburbs, has deployed a comprehensive suite of eRAD solutions to automate its business and clinical workflow.
RDNT: 8.66 (-0.11)
Uptrend Call Working As RadNet Stock Rises 17.9% (RDNT)
Comtex SmarTrend(R) - Fri Nov 21, 9:44AM CST
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on August 8th, 2014 at $6.91. In approximately 4 months, RadNet has returned 17.95% as of today's recent price of $8.15.
RDNT: 8.66 (-0.11)
